ROLE OF A NEW MACHINE MALDI TOF- MS(MATRIX-ASSISTED LASER DESORPTION/IONIZATION-TIME OF FLIGHT MASS SPECTROMETRY) FOR DISEASE CAUSING MICROORGANISMS IDENTIFICATION AND TREATMENT IN ICU PATIENTS

SEPTICEMIA IN CRITICALLY ILL PATIENTS: PROSPECTIVE STUDY ON EPIDEMIOLOGY, RISK FACTOR AND ROLE OF MALDI TOF- MS FOR SPECIES IDENTIFICATION OF THE ORGANISMS CAUSING SEPTICEMIA

Status

Active, not recruiting

Phases

Phase 3

Study type

Observational

Source

CTRI

Registry ID

CTRI/2020/11/029256

Enrollment

200

Registered

2020-11-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A419- Sepsis, unspecified organism

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: â?? Patients/ Guardian giving written consent will be taken â?? Age 16-60 years admitted in ICU â?? Patients having new onset of fever after 48 hours of admission in the hospital. â?? patients having new onset netropenia

Exclusion criteria

Exclusion criteria: â?? Patients not giving consent. â?? Patients already having fever at the time of admission. â?? Patients developing fever within 48h of admission . - patients APACHE score of above 25 -

Design outcomes

Primary

Measure	Time frame
To study epidemiology and risk factor of causative organisms of septicemia in patients admitted in tertiary level ICU care. Role of MALDI TOF MASS SPECTROMETRY in Species identification of the organisms causing septicemia. Antibiotic susceptibility pattern of the organisms causing septicemia. To study incidence of candidemia and antifungal susceptibility. Clinical outcome of the patients in terms of hospital stay and number of days on ventilator. Timepoint: 1.5 years	—

Measure

Time frame

To study epidemiology and risk factor of causative organisms of septicemia in patients admitted in tertiary level ICU care. Role of MALDI TOF MASS SPECTROMETRY in Species identification of the organisms causing septicemia. Antibiotic susceptibility pattern of the organisms causing septicemia. To study incidence of candidemia and antifungal susceptibility. Clinical outcome of the patients in terms of hospital stay and number of days on ventilator. Timepoint: 1.5 years

—

Secondary

Measure	Time frame
To study incidence of candidemia and antifungal susceptibility.Timepoint: 1.5 YEARS	—

Countries

India

Contacts

Public ContactDR KULDEEP SINGH SINDHLIAN

KGMU LUCKNOW

ziaarshad13@gmail.com9415722226

Outcome results